By comprehending the complex interactions of 14-3-3 proteins in neurological disorders, we seek to lay the groundwork for forthcoming therapeutic approaches that harness the versatile potential of these proteins, aiming to address and combat devastating neurological conditions, such as Alzheimer’s disease (AD). Here, YWHAQ is linked to early-onset autosomal dominant Alzheimer disease.